Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Return on Sales (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Sales for 5 consecutive years, with 62.14% as the latest value for Q4 2020.

  • On a quarterly basis, Return on Sales rose 123803.0% to 62.14% in Q4 2020 year-over-year; TTM through Dec 2020 was 62.14%, a 48453.0% increase, with the full-year FY2019 number at 1764.33%, down 176162.0% from a year prior.
  • Return on Sales was 62.14% for Q4 2020 at Forte Biosciences, down from 71.04% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 1639.56% in Q2 2019 to a low of 2157.11% in Q4 2018.
  • A 5-year average of 487.95% and a median of 1.79% in 2018 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: skyrocketed 342722bps in 2019, then tumbled -157132bps in 2020.
  • Forte Biosciences' Return on Sales stood at 8.75% in 2016, then tumbled by -12492bps to 1083.7% in 2017, then crashed by -99bps to 2157.11% in 2018, then surged by 45bps to 1175.89% in 2019, then skyrocketed by 105bps to 62.14% in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Return on Sales are 62.14% (Q4 2020), 71.04% (Q3 2020), and 68.23% (Q2 2020).